|
MiRNAs
|
Expression1
|
Pathway
|
Reference
|
|---|
|
Let-7a
|
up-regulated
|
Caspase–3
|
[76]
|
|
miR-519d
|
up-regulated
|
CDKN1A/p21, PTEN, AKT3, TIMP2
|
[77]
|
|
miR-26a/b
|
down-regulated
|
ULK1
|
[78]
|
|
miR-26b
|
down-regulated
|
TAK1, TAB3
|
[79]
|
|
miR-520b
|
down-regulated
|
ATG7
|
[80]
|
|
miR-491-3p
|
down-regulated
|
Sp3/ABCB1
|
[81]
|
|
miR-122
|
down-regulated
|
MDR1
|
[82]
|
|
ABCB1; ABCF2
|
[83]
|
|
PKM2
|
[84]
|
|
miR-31
|
down-regulated
|
NDRG3
|
[85]
|
|
miR-223
|
down-regulated
|
ABCB1
|
[86]
|
|
miR-133a,miR-326
|
down-regulated
|
ABCC1
|
[87]
|
|
miR-101
|
down-regulated
|
EZH2
|
[88]
|
|
Mcl-1
|
[89]
|
|
miR-199a-3p
|
down-regulated
|
mTOR, c-Met
|
[90]
|
|
miR-215
|
down-regulated
|
DHFR, TS
|
[91]
|
|
miR-145
|
down-regulated
|
Smad3
|
[92]
|
|
miR-503
|
down-regulated
|
MDR1, MRP, ERCC1, Bcl-2
|
[93]
|
- 1miRNAs either up-regulated or down-regulated in adriamycin resistant hepatocellular carcinoma cells
- Note: This table shows 17 miRNAs, their expression level and potential targets in adriamycin resistance of hepatocellular carcinoma
